Urotensin II (U-II) is a cyclic peptide isolated from a fish. Subsequently, human U-II and its
receptor were identified. In rat thoracic aorta U-II triggers powerful vasoconstrictor activity …

Urotensin-II (U-II) is a cyclic peptide identified recently in many mammalian species
including man. U-II and its receptor are expressed in the central nervous system, in the …

Abstract Urotensin II (U-II) is currently the most potent vasoconstrictor identified. This action
is brought about via activation of a G q/11-protein coupled receptor (UT receptor). U-II …

Human urotensin-II (hU-II) is the most potent endogenous cardiostimulant identified to date.
We therefore determined whether hU-II has a possible pathological role by investigating its …

Background/aim: The pathogenesis of Raynaud's phenomenon (RP) has not yet been fully
elucidated. RP is characterized by exaggerated cold-induced vasoconstriction. Urotensin II …

Arterial hypertension is a highly urgent problem of modern medicine since the crisis of blood
pressure control remains open, due to the increasing number of uncontrolled arterial …

Aim: Human urotensin-II (UII) is a cyclic neuropeptide with potent vasoconstrictive activity in
the vasculature. The expression of UII and its receptor (UT) mRNA is detected at high levels …

Background and objectives: In this study, the aim was to investigate Urotensin 2 (U-II) levels
and oxidant/antioxidant system parameters in pregnancies with intrauterine growth …

Objective The goal of this study was to examine the association between urotensin Ⅱ (U Ⅱ)
concentration and the severity of coronary artery disease (CAD). Methods We studied U Ⅱ …

Abstract Objective: Human urotensin II (hUII) is an endocrine hormone that acts as a potent
arterial vasoconstrictor in both in vitro and in vivo studies in animals. We examined, for the …